Abstract
Acute myocardial infarction (AMI) is a clinical form of coronary heart disease, which occurs after coronary arteries' occlusion and irreversible ischemia progression leads to myocardial necrosis. Morbidity and mortality caused by cardiovascular comorbidities, including AIM, are greater in patients with insulin - dependent diabetes than in non - diabetes patients of the same age. One of the reasons for a higher mortality rate from AMI in patients with diabetes may be heart failure. In addition, patients with diabetes and AMI have an increased risk for poor therapy outcomes of AMI compared with non - diabetes patients, and the main reasons are endothelial dysfunction, prothrombotic state, a greater possibility of restenosis, negative vascular remodelling, increased protein glycosylation, and vascular matrix deposition. In this review, we provide an overview of recent literature data and practical knowledge related to the AMI in diabetic patients.
Funder
Ministry of Education, Science and Technological Development of the Republic of Serbia
Publisher
Centre for Evaluation in Education and Science (CEON/CEES)
Reference25 articles.
1. Vasiljević, ed. Akutni koronarni sindrom. ed. O. M., K. V., and B. B.2011, Zavod za udžbenike. 428-59;
2. Krakow EF, Ginsberg JS, and C. MA., Arterial thromboemolism., in Hematology: Basic Principles and Practice. 5th ed., Hoffman R, et al., Editors. 2009, Elsevier Philadelphia. p. 2055-65;
3. Mehta, R.H., et al., Achieving rapid reperfusion with primary percutaneous coronary intervention remains a challenge: insights from American Heart Association's Get With the Guidelines program. Am Heart J, 2008. 155(6): p. 1059-67;
4. Konkle, Simon, and Schafer, Hemostasis, thrombosis, fibrinolysis and cardiovascular disease, in Braunwald's Heart Disease: a textbook of cardiovascular medicine, B. RO., et al., Editors. 2008, Saunders Elsevier. p. 2049-78;
5. NCEP, T.R.o., Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA, 2001. 285(19): p. 2486-97;